Clinical research stakeholders’ experiences of clinical research during COVID-19: a qualitative study
Background The COVID-19 pandemic created a complex high-risk clinical research environment with clinical research activities significantly impacted. Clinical research stakeholders adapted rapidly to new clinical practices; PPE, infection control policies, all while engaging with a more unwell patient demographic. The aim of this study is to explore the experiences of conducting clinical research during COVID-19 with clinical research stakeholders.
Methods This qualitative study of semi-structured interviews conducted with clinical research stakeholders in an acute Hospital setting across a variety of disciplines; Consultant Geriatrician, Clinical Research Nurse, Occupational Therapy, Physiotherapy. Interviews were fully transcribed prior to reflexive thematic analysis. NVivo software was used to support data management and analysis.
Results Three main themes were produced; (1) The challenging COVID-19 clinical research landscape, (2) COVID-19 clinical research communication barriers, and (3) Adaptations and learnings from clinical research during COVID-19.
Conclusions This study explored the experiences of conducting clinical research during COVID-19 with clinical research stakeholders examining challenges faced and adaptations required. The findings inform, equip and support clinical research stakeholders in the event of future adverse public health events.
History
Publication
BMC Research Notes, 2023, 16, 240Publisher
BMCOther Funding information
This research is funded through the Health Research Board of Ireland (HRB) Research Leader Award (RL-2020-010) and unrestricted Medical Education Liaison Group (MELG) Student Research Bursary 2021, University of Limerick, Ireland.Also affiliated with
- Health Research Institute (HRI)
Sustainable development goals
- (3) Good Health and Well-being
External identifier
Department or School
- Allied Health
- School of Medicine